Font Size: a A A
Keyword [pathologic complete response]
Result: 21 - 35 | Page: 2 of 2
21. Chemosonsitivity Of Tumou-infiltrating Regulatory T Cell And Its Association With Breast Cancer Prognosis
22. Predictive Value Of Peripheral Blood Inflammatory Indicators For Efficacy Of Neoadjuvant Chemotherapy In Breast Cancer
23. Prediction Of Efficacy After Neoadjuvant Chemoradiotherapy For Locally Advanced Rectal Cancer Based On Collagen Score
24. Construction A Predictive Model For Pathologic Complete Response Of Neoadjuvant Therapy For Breast Cancer
25. Assessing Curative Effect Of Neoadjuvant Chemotherapy In Breast Cancer By Magnetic Resonance Imaging Combined With Ultrasound
26. Establishment And Verification Of A Prediction Model For Lymph Node Metastasis In Early Breast Cancer And A Prognostic Model For Non-pCR Patients After Neoadjuvant Therapy
27. Differences In Pathologic Complete Response Rates Between HER2 3+ And HER2 2+/FISH Positive Breast Cancer Patients After Neoadjuvant Therapy And Analysis Of The Causes
28. The Differential Expression Of LncRNA BCAR4 In Locally Advanced Breast Cancer And It’s Correlation With The Efficacy Of Neoadjuvant Chemotherapy
29. Prediction Of Treatment Response To Neoadjuvant Therapy In Breast Cancer With MRI And Staging CT-based Radiomics
30. Methodological Study On The Sensitivity Prediction Of Neoadjuvant Chemotherapy For Breast Cancer And Preliminary Exploration Of Related Mechanisms
31. Screening Sensitivity Markers Of Preoperative Concurrent Chemoradiotherapy For Locally Advanced Rectal Cancer By MicroRNA Microarray
32. Exploration Of Prognostic Factors In Triple-Negative Breast Cancer With High Risk Of Recurrence And Progression
33. Markers Associated With Tumor Recurrence In Patients With Breast Cancer After Neoadjuvant Chemotherapy
34. Application Value Of 18F-NOTA-FAPI-04 PET/CT In Neoadjuvant Chemoradiotherapy For Esophageal Squamous Carcinoma:A Prospective Study
35. The Value Of DCE-MRI Combined With Immunohistochemistry In Breast Cancer To Assess Pathological Complete Response After Neoadjuvant Chemotherapy
  <<First  <Prev  Next>  Last>>  Jump to